Breaking News

Today Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
Conference/Events	American Academy of Neurology to hold a virtual meeting » 09:24 04/19/21 04/19 09:24 04/19/21 09:24 ABBV AbbVie $107.93 / +1.05 (+0.98%) , ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) , ABT Abbott $124.37 / +0.4 (+0.32%) , ACAD Acadia Pharmaceuticals $21.17 / -0.02 (-0.09%) , ALNY Alnylam $138.69 / -0.23 (-0.17%) , BIIB Biogen $270.07 / -0.66 (-0.24%) , BMY Bristol-Myers $65.46 / +1.02 (+1.58%) , BHVN Biohaven Pharmaceutical $74.37 / -1.435 (-1.89%) , CPRX Catalyst Pharmaceuticals $4.44 / -0.02 (-0.45%) , DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) , DNA Bought by RHHBY $94.97 / + (+0.00%) , HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) , LIVN LivaNova $81.37 / -1.46 (-1.76%) , LLY Eli Lilly $189.25 / +3.28 (+1.76%) , MDT Medtronic $125.91 / +0.06 (+0.05%) , NVS Novartis $88.02 / +0.81 (+0.93%) , NVTA Invitae $37.65 / -1.47 (-3.76%) , PFE Pfizer $38.57 / +0.96 (+2.55%) , PTCT PTC Therapeutics $48.48 / +0.33 (+0.69%) , RETA Reata Pharmaceuticals $90.83 / -1.29 (-1.40%) , SNY Sanofi $51.29 / +0.63 (+1.24%) , SUPN Supernus $31.72 / -0.09 (-0.28%) , TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) , TEVA Teva $10.75 / -0.08 (-0.74%) , TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) , ZGNX Zogenix $19.00 / -0.65 (-3.31%) , AVDL Avadel Pharmaceuticals $8.65 / +0.09 (+1.05%) , JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 73rd Annual Virtual… 73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options ZGNX TGTX TEVA TAK SUPN SNY RETA PTCT PFE NVTA NVS MDT LLY LIVN JNJ HZNP DGX CPRX BMY BIIB BHVN AVDL ALNY ACAD ABT ABC ABBV ZGNX Zogenix $19.00 / -0.65 (-3.31%) 04/16/21 Zogenix announces new data from study highlighting impact of fintepla treatment 01/11/21 Zogenix announces 2021 corporate objectives 01/11/21 Zogenix sees Q4 FINTEPLA revenue $8.1M 12/21/20 Zogenix announces EC approval of FINTEPLA oral solution TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) 04/16/21 TG Therapeutics announces results from ULTIMATE I & II trials of ublituximab 03/29/21 TG Therapeutics completes rolling submission of BLA for ublituximab w/ UKONIQ 03/09/21 TG Therapeutics announces publication of results from UNITY-NHL trial 03/02/21 TG Therapeutics expects cash to fund planned operations into 2023 TEVA Teva $10.75 / -0.08 (-0.74%) 08:17 Today Teva announces new data on efficacy of AJOVY 04/08/21 Teva receives EU Marketing Authorization for Seffalair Spiromax 03/31/21 CareDx announces new leadership appointments and promotions 03/08/21 Teva announces launch of generic version of Azopt 1% TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 08:03 Today Ovid Therapeutics to discontinue development of OV101 04/14/21 Centogene extends partnership with Takeda Pharmaceutical 04/12/21 Intellia Therapeutics appoints Georgia Keresty to board of directors 04/07/21 Kamada announces amendment to GLASSIA license agreement with Takeda SUPN Supernus $31.72 / -0.09 (-0.28%) 04/05/21 Supernus receives FDA approval for Qelbree for ADHD 02/22/21 Supernus receives FDA notice assigning early April PDUFA date for SPN-812 NDA 02/08/21 Supernus resubmits NDA for SPN-812 for ADHD 12/22/20 Supernus jumps 29% to $29 per share after SPN-812 study meets primary endpoint SNY Sanofi $51.29 / +0.63 (+1.24%) 08:05 Today Sanofi says EC approves second indication of Sarclisa for relapsed MM 07:39 Today Translate Bio announces preclinical results for COVID-19 vaccine candidate 04/16/21 Sanofi completes acquisition of Kiadis Pharma 04/12/21 Sanofi to invest EUR 400M in vaccine production site in Singapore RETA Reata Pharmaceuticals $90.83 / -1.29 (-1.40%) 11/24/20 FDA says Reata's omaveloxolone results do not strengthen Part 2 results 11/10/20 Reata Pharmaceuticals CEO sells 81.7K shares of common stock 11/09/20 Reata Pharma announces results from Phase 3 Cardinal study 10/26/20 Reata Pharmaceuticals study shows omaveloxolone improved neuro function PTCT PTC Therapeutics $48.48 / +0.33 (+0.69%) 04/15/21 PTC Therapeutics announces FIREFISH trial results at AAN virtual meeting 04/01/21 PTC Therapeutics to receive $20M commercial milestone payment from Roche 03/30/21 Roche announces European Commission approval of Evrysdi 03/30/21 PTC Therapeutics granted marketing authorization for Evrysdi from EC PFE Pfizer $38.57 / +0.96 (+2.55%) 05:11 Today Pfizer, BioNTech to supply additional 100M COVID-19 vaccine doses to EU 04/16/21 U.S. exceeds 200M COVID-19 vaccine doses administered 04/16/21 Moderna cuts April vaccine shipment to Canada to 650,000 from 1.2M NVTA Invitae $37.65 / -1.47 (-3.76%) 04/05/21 Invitae announces $1.15B investment supporting ongoing growth initiatives 04/05/21 Invitae to acquire Genosity for approximately $200M 03/09/21 Invitae rises 11.8% 03/08/21 Invitae 'among most important companies' in molecular testing, ARK's Wood says NVS Novartis $88.02 / +0.81 (+0.93%) 04/16/21 AIkido Pharma notes 'positive' early results from PSMA 617-Lu177 study 04/16/21 Ideaya Biosciences announces data from ongoing darovasertib, binimetinib trial 04/12/21 Roche announces FDA approval for Xolair prefilled syringe 04/07/21 Immutep announces European patent grant for LAG525 antibody MDT Medtronic $125.91 / +0.06 (+0.05%) 04/14/21 Medtronic announces European launch of Medtronic Extended infusion set 04/12/21 Medtronic says FDA grants de novo clearance for GI Genius endoscopy module 03/26/21 Medtronic reports FDA approval for Harmony TPV 03/24/21 Medtronic recalling Affinity Pixie device for elevated levels of bacteria LLY Eli Lilly $189.25 / +3.28 (+1.76%) 04/16/21 FDA revokes emergency use authorization for Eli Lilly's bamlanivimab 04/16/21 Eli Lilly requests FDA revoke EUA for bamlanivimab 700 mg alone 04/13/21 Eli Lilly announces Diogo Rau as chief information, digital officer 04/12/21 Innovent/Eli Lilly's phase 3 study of TYVYT in sqNSCLC saw OS improvement LIVN LivaNova $81.37 / -1.46 (-1.76%) 03/03/21 LivaNova up 3% after FT reports on Permira takeover bid 12/03/20 LivaNova to divest heart valve business to Gyrus for $73M, sees dilution 10/29/20 LivaNova CFO Thad Huston stepping down, Alex Shvartsburg appointed Interim CFO JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 09:04 Today Emergent stops manufacturing at Baltimore facility after FDA inspection 04/16/21 J&J sees no 'causal relationship' between Covid vaccine and blood clots 04/15/21 Evelo Biosciences appoints Luca Scavo as CFO, Julie McHugh to board of directors HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) 04/16/21 Horizon Therapeutics announces new Uplizna data at AAN 04/16/21 Horizon Therapeutics announces pooled Tepezza data published 04/07/21 Horizon Therapeutics announces publication of RECIPE trial of Krystexxa data 03/30/21 Horizon Therapeutics to resupply market with Tepezza for TED treatment DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) 04/01/21 Iqvia acquires remaining interest in Q2 Solutions from Quest Diagnostics 04/01/21 Quest Diagnostics sells minority stake in Q2 Solutions to IQVIA for $760M cash 03/15/21 Zora Biosciences signs non-exclusive license agreement with Quest Diagnostics 03/08/21 Quest Diagnostics to acquire outreach laboratory services business of Mercy CPRX Catalyst Pharmaceuticals $4.44 / -0.02 (-0.45%) 03/22/21 Catalyst Pharmaceuticals announces $40M share repurchase program 01/06/21 Catalyst Pharmaceuticals awaiting schedule or decision in FDA suit 01/06/21 Catalyst Pharmaceuticals decides not to pursue Kennedy's disease indication 01/06/21 Catalyst Pharmaceuticals decides not to pursue SMA Type 3 indication BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 04/16/21 Bristol-Myers confirms FDA approves Opdivo combo for gastric cancer 04/16/21 FDA approves Bristol-Myers' Opdivo for initial treatment of gastric cancer 04/14/21 Bristol-Myers receives EC approval for opdivo-cabometyx combination 04/11/21 Bristol-Myers announces results from CheckMate -816 study BIIB Biogen $270.07 / -0.66 (-0.24%) 07:37 Today Biogen announces data from SPINRAZA clinical development program 04/16/21 Biogen presents data from portfolio of multiple sclerosis therapies 04/15/21 Biogen's Tecfidera approved by China's NMPA 04/12/21 Sage, Biogen announce Kinetic study in essential tremor met primary endpoint BHVN Biohaven Pharmaceutical $74.37 / -1.435 (-1.89%) 04/07/21 Biohaven Pharmaceutical rises 11.7% 03/29/21 Biohaven Pharma enrolls first patient in Phase 2/3 trial of oral zavegepant 03/22/21 Biohaven Pharmaceutical CEO: Nurtec growth looks very good 03/17/21 Biohaven Pharmaceutical's Childs buys over 13,000 common shares AVDL Avadel Pharmaceuticals $8.65 / +0.09 (+1.05%) 04/18/21 Avadel presents new data from pivotal REST-ON Phase 3 trial of FT218 03/04/21 Avadel, AASM Foundation partner with Young Investigators Research Forum 03/02/21 Avadel Pharmaceuticals announces publication on FT218 studies 03/01/21 Avadel Pharmaceuticals announces FDA acceptance of FT218 NDA ALNY Alnylam $138.69 / -0.23 (-0.17%) 04/11/21 Alnylam presents late-breaking data from ongoing Phase 1 study of ALN-AGT 04/08/21 Royalty Pharma acquires OXLUMO royalty interest from Dicerna for up to $240M 04/08/21 Royalty Pharma acquires Oxlumo royalty interest from Dicerna for $180M upfront 03/31/21 Alnylam announces NEJM publication of phase3 study of lumasiran in PH1 treatment ACAD Acadia Pharmaceuticals $21.17 / -0.02 (-0.09%) 04/05/21 Acadia receives CRL from FDA for sNDA for pimavanserin 03/22/21 Passage Bio appoints Eliseo Salinas as chief R&D officer 03/08/21 Acadia trading resumes 03/08/21 Acadia says FDA identifies deficiencies that preclude discussion of labeling ABT Abbott $124.37 / +0.4 (+0.32%) 09:07 Today Walgreens Boots Alliance enters agreement with Abbott to sell BinaxNOW 09:03 Today CVS Pharmacy announces availability of over-the-counter COVID-19 testing 08:33 Today Abbott begins shipping BinaxNOW COVID-19 Ag Self Test to retailers 04/08/21 Abbott receives CE mark approval for TriClip device ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 01/06/21 AmerisourceBergen to acquire Alliance Healthcare from Walgreens for $6.5B 11/09/20 AmerisourceBergen names Dr. Lonie Haynes as Chief Diversity & Inclusion Office 11/06/20 AmerisourceBergen reaches agreement with CDC over pharmacy vaccine access 11/05/20 AmerisourceBergen sees FY21 CapEx ~$400M ABBV AbbVie $107.93 / +1.05 (+0.98%) 04/07/21 AbbVie submits regulatory applications for SKYRIZI to FDA, EMA 04/04/21 AbbVie announces extension of review of sNDA of upadacitinib 04/01/21 AbbVie: NEJM publishes 24-week results from Phase 3 RINVOQ study 03/30/21 AbbVie: FDA accepts NDA for atogepant ABBV ABC ABT ACAD ALNY BIIB BMY BHVN CPRX DGX DNA HZNP LIVN LLY MDT NVS NVTA PFE PTCT RETA SNY SUPN TAK TEVA TGTX ZGNX AVDL JNJ ABBV AbbVie $107.93 / +1.05 (+0.98%) 04/06/21 RBC Capital AbbVie transferred with an Outperform at RBC Capital 04/01/21 Piper Sandler Integra to benefit from FDA safety communication, says Piper Sandler 04/01/21 Piper Sandler Piper migraine survey bearish for Amgen, bullish for Biohaven 03/17/21 JPMorgan AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 03/09/21 Baird AmerisourceBergen remains top pick following results, says Baird 02/09/21 Mizuho AmerisourceBergen price target raised to $114 from $104 at Mizuho 02/08/21 Cowen AmerisourceBergen price target raised to $150 from $145 at Cowen 02/04/21 Evercore ISI AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI ABT Abbott $124.37 / +0.4 (+0.32%) 04/15/21 Atlantic Equities Atlantic Equities starts Abbott at Neutral 04/15/21 Atlantic Equities Abbott initiated with a Neutral at Atlantic Equities 03/16/21 Piper Sandler Abbott study challenging Abiomed's Impella halted, says Piper Sandler 03/10/21 Wells Fargo Wells says Quidel Covid testing comments not a direct read through to Abbott ACAD Acadia Pharmaceuticals $21.17 / -0.02 (-0.09%) 04/07/21 Needham Acadia price target lowered to $30 from $44 at Needham 04/07/21 H.C. Wainwright Acadia downgraded to Neutral from Buy at H.C. Wainwright 04/06/21 SVB Leerink Acadia price target lowered to $31 from $63 at SVB Leerink 04/06/21 Jefferies Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL ALNY Alnylam $138.69 / -0.23 (-0.17%) 02/22/21 Guggenheim Alnylam downgraded to Neutral from Buy at Guggenheim 02/12/21 Fly Intel: Top five analyst downgrades 02/12/21 Barclays Alnylam price target raised to $196 from $162 at Barclays 02/12/21 Citi Alnylam downgraded to Neutral from Buy at Citi BIIB Biogen $270.07 / -0.66 (-0.24%) 04/13/21 Roth Capital Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence 04/12/21 Oppenheimer Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer 04/12/21 Wedbush Biogen price target raised to $245 from $236 at Wedbush 03/25/21 Piper Sandler Piper says Biogen Tecfidera patents could change thesis, but sees unknowns BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 04/13/21 Truist Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility 04/13/21 Truist Bristol-Myers upgraded to Buy from Hold at Truist 04/12/21 B. Riley B. Riley calls Agenus the next Seagen, reiterates $8 target 03/08/21 BofA Gartner added to US 1 List, Bristol-Myers removed at BofA BHVN Biohaven Pharmaceutical $74.37 / -1.435 (-1.89%) 03/11/21 Fly Intel: Top five analyst initiations 03/11/21 UBS Biohaven Pharmaceutical initiated with a Buy at UBS 03/02/21 Mizuho Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho CPRX Catalyst Pharmaceuticals $4.44 / -0.02 (-0.45%) 03/16/21 Piper Sandler Catalyst business continues to generate cash flow, says Piper Sandler 01/07/21 Piper Sandler Piper says Catalyst's Firdapse commercial business performing as expected 01/06/21 Piper Sandler Catalyst Firdapse commercial business performing as expected, says Piper Sandler 11/10/20 Piper Sandler Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) 03/12/21 Baird Quest Diagnostics downgraded to Neutral from Outperform at Baird 01/29/21 Citi Quest Diagnostics price target raised to $158 from $151 at Citi 12/17/20 Morgan Stanley Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown 12/17/20 Morgan Stanley Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley DNA Bought by RHHBY $94.97 / + (+0.00%) HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) 03/25/21 Guggenheim Horizon Therapeutics price target raised to $120 from $115 at Guggenheim 03/22/21 Fly Intel: Top five analyst initiations 03/22/21 Morgan Stanley Horizon Therapeutics resumed with an Overweight at Morgan Stanley 03/18/21 Citi Horizon Therapeutics price target raised to $120 from $116 at Citi LIVN LivaNova $81.37 / -1.46 (-1.76%) 04/13/21 Piper Sandler LivaNova price target raised to $92 from $81 at Piper Sandler 03/03/21 Fly Intel: Top five analyst downgrades 03/03/21 Berenberg Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold 03/03/21 Berenberg LivaNova downgraded to Hold from Buy at Berenberg LLY Eli Lilly $189.25 / +3.28 (+1.76%) 04/12/21 Benchmark Benchmark sees full FDA approval of Regeneron's REGEN-COV coming 04/06/21 JPMorgan JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug 03/24/21 BMO Capital AbCellera price target lowered to $59 from $61 at BMO Capital 03/17/21 Mizuho AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho MDT Medtronic $125.91 / +0.06 (+0.05%) 04/15/21 Atlantic Equities Atlantic Equities starts Medtronic at Overweight 04/15/21 Atlantic Equities Medtronic initiated with an Overweight at Atlantic Equities 04/05/21 Citi Citi opens positive catalyst watches on four medical supply stocks 02/24/21 Cowen Medtronic price target raised to $135 from $120 at Cowen NVS Novartis $88.02 / +0.81 (+0.93%) 04/05/21 Morgan Stanley Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley 03/23/21 Societe Generale Novartis price target raised to CHF 107 from CHF 104 at Societe Generale 03/22/21 Bernstein Novartis initiated with a Market Perform at Bernstein 03/10/21 Fly Intel: Top five analyst downgrades NVTA Invitae $37.65 / -1.47 (-3.76%) 04/05/21 Oppenheimer Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock 04/05/21 Oppenheimer Invitae upgraded to Outperform from Perform at Oppenheimer 02/18/21 Ladenburg Invitae upgraded to Buy with $58 price target at Ladenburg 02/18/21 Ladenburg Invitae upgraded to Buy from Neutral at Ladenburg PFE Pfizer $38.57 / +0.96 (+2.55%) 04/13/21 Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 04/13/21 JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital PTCT PTC Therapeutics $48.48 / +0.33 (+0.69%) 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation 03/29/21 RBC Capital PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital 02/26/21 Cantor Fitzgerald PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald 02/12/21 BofA PTC Therapeutics downgraded to Neutral from Buy at BofA RETA Reata Pharmaceuticals $90.83 / -1.29 (-1.40%) 11/25/20 Citi Reata Pharmaceuticals price target lowered to $234 from $260 at Citi 11/10/20 Cantor Fitzgerald Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald 11/10/20 Citi Reata Pharmaceuticals price target raised to $260 from $244 at Citi 08/11/20 Cantor Fitzgerald Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald SNY Sanofi $51.29 / +0.63 (+1.24%) 04/06/21 Barclays Sanofi price target raised to EUR 85 from EUR 80 at Barclays 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list 02/10/21 Morgan Stanley Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley 02/05/21 Piper Sandler Piper reiterates Overweight on Kymera after Sanofi capital markets day SUPN Supernus $31.72 / -0.09 (-0.28%) 04/13/21 Jefferies Supernus upgraded to Buy after survey work at Jefferies 04/13/21 Jefferies Supernus upgraded to Buy from Hold at Jefferies 02/03/21 Piper Sandler Supernus price target raised to $35 from $30 at Piper Sandler 06/16/20 Piper Sandler Supernus upgraded to Overweight from Neutral at Piper Sandler TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 09:04 Today JPMorgan Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan 09:00 Today JPMorgan Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan 04/15/21 Oppenheimer Molecular Templates price target lowered to $13 from $18 at Oppenheimer 04/05/21 Fly Intel: Top five analyst downgrades TEVA Teva $10.75 / -0.08 (-0.74%) 04/06/21 RBC Capital Teva transferred with a Sector Perform at RBC Capital 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 12/21/20 Gabelli Teva named 'Best Idea for 2021' at Gabelli 11/27/20 H.C. Wainwright Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) 07:12 Today Cantor Fitzgerald TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald 06:14 Today H.C. Wainwright TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright 03/04/21 B. Riley TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities 02/09/21 B. Riley TG Therapeutics price target raised to $95 from $90 at B. Riley Securities ZGNX Zogenix $19.00 / -0.65 (-3.31%) 04/06/21 Evercore ISI Evercore starts 'compelling' Arena spinoff Longboard at Outperform 04/06/21 Citi Longboard Pharmaceuticals initiated with a Buy at Citi 02/03/21 Mizuho Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho 12/04/20 Mizuho Zogenix collaboration step in right direction, says Mizuho AVDL Avadel Pharmaceuticals $8.65 / +0.09 (+1.05%) 03/10/21 H.C. Wainwright Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright 01/25/21 Craig-Hallum Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum 08/28/20 Oppenheimer Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer 08/28/20 SVB Leerink Avadel selloff on Jazz competition worries overdone, says SVB Leerink JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 09:14 Today Chardan Chardan sees J&J moving forward with Emergent if observations are minor 04/14/21 Guggenheim Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim 04/13/21 Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs ZGNX TGTX TEVA TAK SUPN SNY RETA PTCT PFE NVTA NVS MDT LLY LIVN JNJ HZNP DGX CPRX BMY BIIB BHVN AVDL ALNY ACAD ABT ABC ABBV ZGNX Zogenix $19.00 / -0.65 (-3.31%) 02/25/21 Zogenix reports Q4 EPS ($1.26), consensus ($1.00) 11/09/20 Zogenix reports Q3 EPS ($1.08), consensus (98c) TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) 03/02/21 TG Therapeutics reports Q4 EPS (71c), consensus (58c) 11/09/20 TG Therapeutics reports Q EPS (73c), consensus (41c) TEVA Teva $10.75 / -0.08 (-0.74%) 02/10/21 Teva sees Q1 lowest for EPS, sales in FY21 02/10/21 Teva sees FY21 EBITDA $4.8B-$5.1B 02/10/21 Teva sees FY21 EPS $2.50-$2.70, consensus $2.63 02/10/21 Teva reports Q4 EPS 68c, consensus 63c TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda SUPN Supernus $31.72 / -0.09 (-0.28%) 02/25/21 Supernus sees FY21 revenue $550M-$580M, consensus $581.47M 02/25/21 Supernus reports Q4 EPS 57c, consensus 52c 11/03/20 Supernus raises FY20 GAAP operating earnings view to $145M-$160M from $90M-$110M 11/03/20 Supernus reports Q3 EPS 74c, consensus 30c SNY Sanofi $51.29 / +0.63 (+1.24%) 02/05/21 Sanofi reports Q4 business EPS EUR 1.22, flat vs. last year 10/29/20 Sanofi reports Q3 business EPS EUR 1.83, up 0.5% from last year RETA Reata Pharmaceuticals $90.83 / -1.29 (-1.40%) 03/01/21 Reata Pharmaceuticals reports Q4 EPS ($1.90), consensus ($2.16) 11/09/20 Reata Pharmaceuticals reports Q3 adj. EPS ($1.31), consensus ($1.98) PTCT PTC Therapeutics $48.48 / +0.33 (+0.69%) 02/25/21 PTC Therapeutics reports Q4 EPS ($1.08), consensus (94c) 10/29/20 PTC Therapeutics reports Q3 EPS ($1.03), consensus (6c) PFE Pfizer $38.57 / +0.96 (+2.55%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open NVTA Invitae $37.65 / -1.47 (-3.76%) 02/17/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $488.37M 02/17/21 Invitae reports Q4 adjusted EPS (63c), consensus (55c) 01/11/21 Invitae sees FY21 revenue 'in excess of' $450M, consensus $513.7M 01/11/21 Invitae reports preliminary FY20 revenue $278M+, consensus $274.93M NVS Novartis $88.02 / +0.81 (+0.93%) 01/26/21 Novartis sees 2021 core operating income to grow mid single digit 01/26/21 Novartis reports Q4 core EPS $1.34, consensus $1.36 11/05/20 Xoma reports Q3 EPS (10c), consensus (21c) 10/27/20 Novartis raises FY20 core operating income growth outlook MDT Medtronic $125.91 / +0.06 (+0.05%) 03/09/21 Titan Medical announces two future corporate milestones 02/23/21 Medtronic reports Q3 EPS $1.29, consensus $1.15 11/24/20 Medtronic reports Q2 EPS $1.02, consensus 80c LLY Eli Lilly $189.25 / +3.28 (+1.76%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open LIVN LivaNova $81.37 / -1.46 (-1.76%) 02/24/21 LivaNova sees 2021 adjusted EPS $1.40-$1.90, consensus $1.98 02/24/21 LivaNova reports Q4 adjusted EPS 71c, consensus 66c 10/29/20 LivaNova still sees FY20 adjusted EPS $1.15-$1.35, consensus $1.18 10/29/20 LivaNova reports Q3 adjusted EPS 38c, consensus 20c JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) 02/24/21 Horizon Therapeutics sees FY21 revenue $2.70B-$2.80B, consensus $2.68B 02/24/21 Horizon Therapeutics reports Q4 EPS $1.28, consensus $1.06 01/11/21 Horizon Therapeutics sees FY20 revenue above $2.12B-$2.14B, consensus $2.13B 11/23/20 Halozyme raises FY20 EPS view to 90c-95c from 80c-85c, consensus 86c DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) 04/01/21 Iqvia raises FY21 EPS view to $7.89 -$8.20 from $7.77 - $8.08 , consensus $7.98 04/01/21 Iqvia raises FY21 EPS view to $7.89 -$8.20 from $7.77 - $8.08 , consensus $7.98 03/11/21 Quest Diagnostics backs first half adjusted EPS view $5.90-$6.90 at investor day 02/04/21 Quest Diagnostics sees first half adjusted EPS $5.90-$6.90 CPRX Catalyst Pharmaceuticals $4.44 / -0.02 (-0.45%) 03/15/21 Catalyst Pharmaceuticals reports Q4 adjusted EPS 12c, consensus 9c 03/15/21 Catalyst Pharmaceuticals reports Q4 EPS 11c, consensus 9c 01/06/21 Catalyst Pharmaceuticals sees 2020 Firdapse revenues approx. $118M 11/09/20 Catalyst Pharmaceuticals reports Q3 diluted EPS 42c, consensus 10c BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 03/04/21 Repare Therapeutics reports Q4 EPS ($2.66), consensus (39c) 02/24/21 CytomX Therapeutics reports Q4 revenue $16.4M, consensus $15.4M 02/04/21 Bristol-Myers boosts FY21 adjusted EPS view to $7.35-$7.55 from $7.15-$7.45 02/04/21 Bristol-Myers reports Q4 adjusted EPS $1.46, consensus $1.41 BIIB Biogen $270.07 / -0.66 (-0.24%) 02/03/21 Biogen sees FY21 adjusted EPS $17.00-$18.50, consensus $24.67 02/03/21 Biogen reports Q4 adjusted EPS $4.58, consensus $4.87 BHVN Biohaven Pharmaceutical $74.37 / -1.435 (-1.89%) 04/07/21 Biohaven Pharmaceutical sees Q1 NURTEC ODT net product revenue $43.8M 03/01/21 Biohaven Pharmaceutical reports Q4 adjusted EPS ($2.69), consensus ($2.97) 11/09/20 Biohaven Pharmaceutical reports Q3 adj. EPS ($2.67), consensus ($2.89) AVDL Avadel Pharmaceuticals $8.65 / +0.09 (+1.05%) 03/09/21 Avadel Pharmaceuticals reports Q4 EPS (19c), consensus (27c) 11/09/20 Avadel Pharmaceuticals reports Q3 EPS (20c), consensus (25c) ALNY Alnylam $138.69 / -0.23 (-0.17%) 02/11/21 Alnylam sees FY21 product revenue $610M-$660M 02/11/21 Alnylam reports Q4 non-GAAP EPS ($1.60), consensus ($1.76) 11/05/20 Alnylam reports Q3 EPS ($1.58), consensus ($1.66) ACAD Acadia Pharmaceuticals $21.17 / -0.02 (-0.09%) 02/24/21 Acadia sees FY21 revenue $510M-$550M, consensus $676.18M 02/24/21 Acadia reports Q4 EPS (42c), consensus (47c) 11/04/20 Acadia backs FY20 NUPLAZID net sales view of $430M-$450M 11/04/20 Acadia reports Q3 EPS (54c), consensus (38c) ABT Abbott $124.37 / +0.4 (+0.32%) 01/27/21 Abbott sees FY21 adjusted EPS from continuing operations of at least $5.00 01/27/21 Abbott reports Q4 adjusted EPS $1.45, consensus $1.35 01/26/21 Notable companies reporting before tomorrow's open ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 02/04/21 AmerisourceBergen raises FY21 adjusted EPS view to $8.40-$8.60 from $8.25-$8.50 02/04/21 AmerisourceBergen reports Q1 adjusted EPS $2.18, consensus $1.94 02/03/21 Notable companies reporting before tomorrow's open ABBV AbbVie $107.93 / +1.05 (+0.98%) 02/03/21 AbbVie sees FY21 adjusted EPS $12.32-$12.52, consensus $12.18 02/03/21 AbbVie reports Q4 adjusted EPS $2.92, consensus $2.85 02/02/21 Notable companies reporting before tomorrow's open 16 Mar 22 Jan 15 Dec 02 Dec 07 Aug 15 May 29 Apr TEVA SNY PFE NVS LLY LIVN JNJ BMY BIIB ALNY ABT ABC ABBV TEVA Teva $10.75 / -0.08 (-0.74%) 02/10/21 CEO says Teva in discussions to co-produce COVID vaccine, Reuters reports 02/09/21 Teva wins new hearing on $235M GSK patent verdict, Bloomberg reports 11/13/20 Teva facing EU antitrust investigation over Copaxone sales, Bloomberg reports SNY Sanofi $51.29 / +0.63 (+1.24%) 02/15/21 CEO says Sanofi mRNA vaccine won't be ready this year, Bloomberg reports 02/11/21 Amgen loses appeal to revive PCSK9 antibody patent suit, Bloomberg reports PFE Pfizer $38.57 / +0.96 (+2.55%) 04/18/21 Japan, Pfizer agree on more vaccine supply, Bloomberg reports 04/16/21 Canada secures 8M additional Pfizer COVID-19 vaccine doses, CTV News says 04/16/21 J&J reached out to vaccine rivals to study blood clot risk, WSJ reports 04/15/21 Pfizer CEO tells CNBC third vaccine dose likely needed within 12 months NVS Novartis $88.02 / +0.81 (+0.93%) 03/15/21 BioNTech recruits Novartis, Sanofi to boost vaccine production, WSJ reports 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports LLY Eli Lilly $189.25 / +3.28 (+1.76%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says LIVN LivaNova $81.37 / -1.46 (-1.76%) 03/03/21 PE firm Permira has made bid to buy LivaNova, FT reports JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 06:32 Today J&J COVID-19 vaccine paused, concerns of mistreating blood clots, WSJ reports 04/18/21 Fauci predicts resumption of J&J COVID vaccine use, Reuters reports 04/15/21 CDC advisers to tentatively reconvene next week on J&J vaccine, Bloomberg says BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 04/01/21 Accidental disclosure show Bristol-Myers, I.R.S. $1B tax fight, NY Times reports 02/15/21 Bristol-Myers, Sanofi to pay $834M over Plavix, Bloomberg reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says BIIB Biogen $270.07 / -0.66 (-0.24%) 04/04/21 Tesla, Facebook hired through pandemic as GE, others shed jobs, WSJ says 03/20/21 Still reasons to be hopeful about Lilly, Biogen Alzheimer's drugs, Barron's says 03/17/21 Biogen, Alkermes sue Teva to block MS drug, Bloomberg reports 11/07/20 Biogen Alzheimer's drug closer to approval, still not a buy, Barron's says ALNY Alnylam $138.69 / -0.23 (-0.17%) 11/23/20 Alnylam gets FDA approval for Oxlumo, Bloomberg reports ABT Abbott $124.37 / +0.4 (+0.32%) 03/16/21 Abbott confirms to Bloomberg suspension of trial enrollment ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 11/05/20 Distributors and J&J closing in on $26B opioid settlement deal, NY Times says ABBV AbbVie $107.93 / +1.05 (+0.98%) 03/15/21 AbbVie in discussions to sell $5B women's drug portfolio, Reuters reports 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says 12/16/20 AbbVie unit wins ITC trade secret case against Evolus, Bloomberg says 12/09/20 Former Allergan CEO's SPAC to merge with HydraFacial Co, WSJ reports ZGNX TGTX TEVA TAK SUPN SNY RETA PTCT PFE NVTA NVS LLY JNJ HZNP DGX CPRX BMY BIIB BHVN AVDL ACAD ABT ABC ABBV ZGNX Zogenix $19.00 / -0.65 (-3.31%) 02/03/21 Analysts spotlight Zynerba, Zogenix after Jazz agrees to buy CBD medicine maker 11/09/20 Fly Intel: After-Hours Movers TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) 02/05/21 Fly Intel: Wall Street's top stories for Friday 12/10/20 Fly Intel: Wall Street's top stories for Thursday 12/10/20 Fly Intel: Wall Street's top stories at midday TEVA Teva $10.75 / -0.08 (-0.74%) 02/10/21 Fly Intel: Wall Street's top stories for Wednesday 02/10/21 Fly Intel: Wall Street's top stories at midday 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers SUPN Supernus $31.72 / -0.09 (-0.28%) 12/23/20 Fly Intel: Wall Street's top stories for Wednesday 12/23/20 Fly Intel: Wall Street's top stories at midday 11/04/20 Fly Intel: Wall Street's top stories for Wednesday SNY Sanofi $51.29 / +0.63 (+1.24%) 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 12/31/20 Fly Intel: Wall Street's top stories for Thursday RETA Reata Pharmaceuticals $90.83 / -1.29 (-1.40%) 12/01/20 Fly Intel: After-Hours Movers 11/24/20 Fly Intel: After-Hours Movers PTCT PTC Therapeutics $48.48 / +0.33 (+0.69%) 03/23/21 Ionis Pharmaceuticals slides as Wall Street digests HD program setback PFE Pfizer $38.57 / +0.96 (+2.55%) 04/16/21 Fly Intel: Wall Street's top stories for Friday 04/15/21 Fly Intel: Wall Street's top stories for Thursday 04/13/21 Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine 04/10/21 Opening Day: Phone maker UTime soars in public debut NVTA Invitae $37.65 / -1.47 (-3.76%) 01/20/21 Fly Intel: After-Hours Movers NVS Novartis $88.02 / +0.81 (+0.93%) 03/10/21 Novartis downgrade, HP Enterprise upgrade among today's top calls on Wall Street 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 02/11/21 Fly Intel: Pre-market Movers LLY Eli Lilly $189.25 / +3.28 (+1.76%) 03/15/21 Fly Intel: Wall Street's top stories for Monday 03/15/21 Fly Intel: Wall Street's top stories at midday 03/15/21 Fly Intel: Pre-market Movers 03/10/21 Fly Intel: Wall Street's top stories for Wednesday JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 04/16/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) 02/01/21 Fly Intel: Wall Street's top stories for Monday 02/01/21 Fly Intel: Wall Street's top stories at midday 11/02/20 Fly Intel: Pre-market Movers DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) 03/16/21 Higher COVID vaccine reimbursement seen as 'windfall' for drug retailers 12/17/20 AT&T downgrade, Yum! Brands upgrade among today's top calls on Wall Street 12/16/20 Fly Intel: Pre-market Movers CPRX Catalyst Pharmaceuticals $4.44 / -0.02 (-0.45%) 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/22/21 Fly Intel: Wall Street's top stories at midday BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 04/13/21 FedEx, Booking Holdings upgrades among today's top calls on Wall Street 03/29/21 Fly Intel: Pre-market Movers 02/09/21 Fly Intel: Pre-market Movers 12/26/20 Week in review: How Trump's policies moved stocks BIIB Biogen $270.07 / -0.66 (-0.24%) 01/29/21 Fly Intel: Wall Street's top stories for Friday BHVN Biohaven Pharmaceutical $74.37 / -1.435 (-1.89%) 04/07/21 Fly Intel: Wall Street's top stories for Wednesday 04/07/21 Fly Intel: Wall Street's top stories at midday 03/22/21 Fly Insider: Thryv, Abeona among week's notable insider trades AVDL Avadel Pharmaceuticals $8.65 / +0.09 (+1.05%) 11/09/20 Fly Intel: Pre-market Movers ACAD Acadia Pharmaceuticals $21.17 / -0.02 (-0.09%) 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Pre-market Movers 03/09/21 Fly Intel: Wall Street's top stories for Tuesday ABT Abbott $124.37 / +0.4 (+0.32%) 03/08/21 Fly Insider: Wayfair, Affirm among week's notable insider trades 01/27/21 Fly Intel: Wall Street's top stories at midday 01/27/21 Fly Intel: Pre-market Movers ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 02/04/21 Fly Intel: Pre-market Movers 01/06/21 Fly Intel: Wall Street's top stories for Wednesday 01/06/21 Fly Intel: Wall Street's top stories at midday 01/06/21 Fly Intel: Pre-market Movers ABBV AbbVie $107.93 / +1.05 (+0.98%) 02/19/21 Fly Intel: Wall Street's top stories for Friday 02/03/21 Fly Intel: Wall Street's top stories for Wednesday 02/03/21 Fly Intel: Wall Street's top stories at midday 02/03/21 Fly Intel: Pre-market Movers 05/24/21 Global Healthcare Virtual Conference 2021 16:00 Today Alnylam - ALNY 04/20/21 Johnson & Johnson - JNJ 04/20/21 Abbott - ABT 04/22/21 Biogen - BIIB 04/22/21 Quest Diagnostics - DGX 04/27/21 Eli Lilly - LLY 04/28/21 LivaNova - LIVN 04/28/21 Teva - TEVA 04/28/21 Sanofi - SNY 04/29/21 Alnylam - ALNY 04/29/21 Bristol-Myers - BMY 04/30/21 AbbVie - ABBV 05/04/21 Pfizer - PFE 05/05/21 Horizon Therapeutics - HZNP 05/05/21 AmerisourceBergen - ABC 04/29/21 Oncologic Drugs Advisory Committee Virtual Meeting 05/18/21 PDUFA Date for Avalglucosidase Alfa 05/20/21 PDUFA Date for CM-577 - Opdivo 05/25/21 PDUFA Date for CM-649 Opdivo+ Yervoy or Chemo 05/30/21 PDUFA Date for Zeposia (Ozanimod) 06/07/21 PDUFA Date for Aducanumab 06/15/21 PDUFA Date for Umbralisib (FL Indication--Standard Review) 10/15/21 PDUFA Date for FT218 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 01/28/22 PDUFA Date for Mavacamten 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/23/21 Abbott Laboratories 05/03/21 Eli Lilly & Co. 05/04/21 Bristol Myers Squibb Co 05/06/21 Eli Lilly 05/07/21 AbbVie Inc. 05/18/21 Alnylam Pharmaceuticals Inc. 05/21/21 Quest Diagnostics Incorporated 05/27/21 Zogenix, Inc. 06/02/21 Biogen Inc ZGNX TGTX TEVA TAK PFE NVTA MDT LLY JNJ HZNP DGX BMY BIIB ABT ABC ABBV ZGNX Zogenix $19.00 / -0.65 (-3.31%) 11/19/20 Unusual call flow in option market yesterday 11/18/20 Upside call Seller in Zogenix TGTX TG Therapeutics $44.79 / -1.05 (-2.29%) 12/11/20 TG Therapeutics call volume above normal and directionally bullish TEVA Teva $10.75 / -0.08 (-0.74%) 02/02/21 Teva call volume above normal and directionally bullish 01/19/21 Teva call volume above normal and directionally bullish 01/06/21 Notable open interest changes for January 6th 01/04/21 Teva call volume above normal and directionally bullish TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/06/21 Largest borrow rate increases among liquid names 04/05/21 Largest borrow rate increases among liquid names 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish PFE Pfizer $38.57 / +0.96 (+2.55%) 04/16/21 Pfizer call volume above normal and directionally bullish 04/16/21 Unusually active option classes on open April 16th 04/15/21 Pfizer call volume above normal and directionally bullish 04/12/21 Unusually active option classes on open April 12th NVTA Invitae $37.65 / -1.47 (-3.76%) 12/07/20 Invitae call volume above normal and directionally bullish 11/12/20 Invitae call volume above normal and directionally bullish 11/11/20 Invitae call volume above normal and directionally bullish MDT Medtronic $125.91 / +0.06 (+0.05%) 03/31/21 Medtronic call volume above normal and directionally bullish 03/24/21 Medtronic call volume above normal and directionally bullish 02/23/21 Early notable gainers among liquid option names on February 23rd LLY Eli Lilly $189.25 / +3.28 (+1.76%) 03/11/21 Eli Lilly call volume above normal and directionally bullish 03/10/21 Eli Lilly call volume above normal and directionally bullish 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th JNJ Johnson & Johnson $162.24 / +1.74 (+1.08%) 04/13/21 Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th HZNP Horizon Therapeutics $93.25 / -0.32 (-0.34%) 12/01/20 Unusual call flow in option market yesterday 11/30/20 Ratio call spread buyer building position in Horizon Pharma DGX Quest Diagnostics $130.09 / +0.86 (+0.67%) 10/23/20 Early notable gainers among liquid option names on October 23rd BMY Bristol-Myers $65.46 / +1.02 (+1.58%) 04/07/21 Unusually active option classes on open April 7th 01/20/21 Unusually active option classes on open January 20th 01/11/21 Unusually active option classes on open January 11th 01/05/21 Bristol Myers Squibb call volume above normal and directionally bullish BIIB Biogen $270.07 / -0.66 (-0.24%) 03/25/21 Early notable gainers among liquid option names on March 25th 01/29/21 Early notable gainers among liquid option names on January 29th 01/08/21 Biogen put volume heavy and directionally bearish 11/11/20 Early notable gainers among liquid option names on November 11th ABT Abbott $124.37 / +0.4 (+0.32%) 01/28/21 Early notable gainers among liquid option names on January 28th ABC AmerisourceBergen $119.62 / +0.55 (+0.46%) 01/06/21 Early notable gainers among liquid option names on January 6th ABBV AbbVie $107.93 / +1.05 (+0.98%) 03/17/21 Unusually active option classes on open March 17th 02/05/21 Unusually active option classes on open February 5th 01/27/21 AbbVie put volume heavy and directionally bearish 11/10/20 AbbVie call volume above normal and directionally bullish
Downgrade	Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan » 09:04 04/19/21 04/19 09:04 04/19/21 09:04 TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 08:03 Today Ovid Therapeutics to discontinue development of OV101 04/14/21 Centogene extends partnership with Takeda Pharmaceutical 04/12/21 Intellia Therapeutics appoints Georgia Keresty to board of directors 04/07/21 Kamada announces amendment to GLASSIA license agreement with Takeda TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 09:00 Today JPMorgan Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan 04/15/21 Oppenheimer Molecular Templates price target lowered to $13 from $18 at Oppenheimer 04/05/21 Fly Intel: Top five analyst downgrades 04/05/21 Barclays Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/06/21 Largest borrow rate increases among liquid names 04/05/21 Largest borrow rate increases among liquid names 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish 03/17/21 Unusually active option classes on open March 17th
Downgrade	Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan » 09:00 04/19/21 04/19 09:00 04/19/21 09:00 TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) JPMorgan analyst Seiji… JPMorgan analyst Seiji Wakao downgraded Takeda Pharmaceutical to Neutral from Overweight with a 4,200 yen price target. ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 08:03 Today Ovid Therapeutics to discontinue development of OV101 04/14/21 Centogene extends partnership with Takeda Pharmaceutical 04/12/21 Intellia Therapeutics appoints Georgia Keresty to board of directors 04/07/21 Kamada announces amendment to GLASSIA license agreement with Takeda TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/15/21 Oppenheimer Molecular Templates price target lowered to $13 from $18 at Oppenheimer 04/05/21 Fly Intel: Top five analyst downgrades 04/05/21 Barclays Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays 04/05/21 Jefferies Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/06/21 Largest borrow rate increases among liquid names 04/05/21 Largest borrow rate increases among liquid names 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish 03/17/21 Unusually active option classes on open March 17th
Recommendations	Las Vegas Sands price target raised to $71 from $66 at Jefferies » 08:50 04/19/21 04/19 08:50 04/19/21 08:50 LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) Jefferies analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 04/01/21 Macau reports March casino revenue up 58.0% to 8.31B patacas 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M 03/18/21 Connecticut Governor Lamont, tribes reach gambling agreement 03/03/21 VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 03/29/21 Deutsche Bank New York may be 'kicking the can' on sports betting, says Deutsche 03/18/21 JPMorgan Micro-betting market in U.S. 'could be substantial,' says JPMorgan LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 04/14/21 Las Vegas Sands running ads to campaign for Texas casinos, Texas Tribune reports 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 04/16/21 Bet On It: Arizona legalizes sports betting, while Maryland nears finish line 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 04/01/21 Macau gaming revenue continues streak, gaining 58% year-over-year in March 04/21/21 Las Vegas Sands - LVS 05/13/21 Las Vegas Sands Corp. LVS Las Vegas Sands $61.00 / -0.3 (-0.49%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd
Hot Stocks	Ovid Therapeutics to discontinue development of OV101 » 08:03 04/19/21 04/19 08:03 04/19/21 08:03 OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) , TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) Ovid Therapeutics (OVID)… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options TAK OVID TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/14/21 Centogene extends partnership with Takeda Pharmaceutical 04/12/21 Intellia Therapeutics appoints Georgia Keresty to board of directors 04/07/21 Kamada announces amendment to GLASSIA license agreement with Takeda 03/31/21 Takeda Pharmaceutical completes sale of OTC, non-core assets to Orifarm OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) 03/30/21 Ovid Therapeutics, Takeda close agreement for commercialization of soticlestat 03/03/21 Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 12/16/20 Ovid Therapeutics announces addition to Nasdaq Biotechnology Index 12/01/20 Ovid Therapeutics falls 43% to $3.75 after failed ph.3 trial of OV101 OVID TAK OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) 03/04/21 Citi Ovid Therapeutics price target raised to $5 from $4 at Citi 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 03/03/21 RBC Capital Ovid Therapeutics downgraded to Sector Perform from Outperform at RBC Capital 12/02/20 RBC Capital Ovid Therapeutics price target lowered to $5 from $17 at RBC Capital TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/15/21 Oppenheimer Molecular Templates price target lowered to $13 from $18 at Oppenheimer 04/05/21 Fly Intel: Top five analyst downgrades 04/05/21 Barclays Molecular Templates MT-3724 discontinuation shouldn't be surprise, says Barclays 04/05/21 Jefferies Takeda Pharmaceutical downgraded to Hold from Buy at Jefferies TAK OVID TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/05/21 Molecular Templates to assume full rights of TAK-169 from Takeda OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) 03/15/21 Ovid Therapeutics reports Q4 EPS (34c), consensus (31c) 11/12/20 Ovid Therapeutics reports Q3 EPS (28c), consensus (36c) 25 Aug OVID OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 12/02/20 Fly Intel: Wall Street's top stories for Wednesday TAK OVID TAK Takeda Pharmaceutical $17.08 / -0.13 (-0.76%) 04/06/21 Largest borrow rate increases among liquid names 04/05/21 Largest borrow rate increases among liquid names 03/19/21 Takeda Pharmaceutical call volume above normal and directionally bullish 03/17/21 Unusually active option classes on open March 17th OVID Ovid Therapeutics $3.79 / -0.025 (-0.66%) 03/12/21 Largest borrow rate increases among liquid names 03/03/21 Unusually active option classes on open March 3rd

Yesterday
Downgrade	OneMain Holdings downgraded to Market Perform from Outperform at BMO Capital » 19:36 04/18/21 04/18 19:36 04/18/21 19:36 OMF OneMain Holdings $55.96 / +0.73 (+1.32%) , KKR KKR $53.29 / +0.36 (+0.68%) , APO Apollo Global $51.54 / +1.27 (+2.53%) , BEN Franklin Resources $30.05 / -0.24 (-0.79%) , VCTR Victory Capital $27.48 / -0.25 (-0.90%) , MS Morgan Stanley $78.58 / -2.31 (-2.86%) , GS Goldman Sachs $342.30 / +3.71 (+1.10%) BMO Capital analyst James… BMO Capital analyst James Fotheringham downgraded OneMain Holdings (OMF) to Market Perform from Outperform with an unchanged price target of $60. The analyst cites "exclusively" valuation for the downgrade. The shares have tripled over the past year and are now well above historical averages, Fotheringham tells investors in a research note. The analyst notes that he's not making a call on the upcoming quarter. He prefers market-oriented asset managers like KKR (KKR), Apollo Global (APO) , Franklin Resources (BEN), and Victory Capital (VCTR) as well as investment banks Morgan Stanley (MS) and Goldman Sachs (GS). ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VCTR OMF MS KKR GS BEN APO VCTR Victory Capital $27.48 / -0.25 (-0.90%) 04/13/21 Victory Capital reports AUM $154.3B as of March 31st 03/10/21 Victory Capital reports AUM $150.6B as of February 28th 03/08/21 Victory Capital announces Alderwood secures FCA authorization 02/10/21 Victory Capital reports AUM of $146.2B as of January 31 OMF OneMain Holdings $55.96 / +0.73 (+1.32%) 02/09/21 OneMain Holdings sees FY21 net charge-offs less than 6% 11/25/20 OneMain Holdings chairman Levine sells 56.6K shares of common stock 11/20/20 OneMain chairman Levine sells 15,724 common shares 10/27/20 OneMain Holdings sees FY20 net charge-offs ~5.6%, down from prior outlook MS Morgan Stanley $78.58 / -2.31 (-2.86%) 04/16/21 Morgan Stanley says 'very active' in recruiting advisors 04/16/21 Morgan Stanley expects net interest income to grow from current levels 04/16/21 Morgan Stanley says investment banking pipelines 'healthy across products' 04/16/21 Morgan Stanley says Archegos exit 'money well spent' KKR KKR $53.29 / +0.36 (+0.68%) 04/14/21 KKR to acquire Ensono from Charlesbank Capital, M/C Partners, no terms disclosed 04/14/21 KKR to acquire Ensono from Charlesbank Capital, M/C Partners 04/13/21 Epic Games completes $1B round of funding, including $200M investment from Sony 04/08/21 KKR to lead purchase of $500M of convertible preferred stock in Box GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/15/21 Congress to host big bank CEOs for hearings the week of May 24 04/14/21 Goldman Sachs CEO: 'Not focused' on offering crypto wallet right now 04/14/21 Goldman Sachs CEO: 'We have a plan at the moment to build a digital bank' 04/14/21 Goldman Sachs says investment banking backlog ended at record levels in Q1 BEN Franklin Resources $30.05 / -0.24 (-0.79%) 04/12/21 Franklin Resources reports AUM of nearly $1.5T at March 31 03/25/21 Franklin Resources' Plafker sells over 20,000 common shares 03/09/21 Franklin Resources reports preliminary AUM $1.5T as of February 28 APO Apollo Global $51.54 / +1.27 (+2.53%) 04/15/21 Apollo Global announces completion of tender offer for shares of Michaels 04/15/21 B. Riley Financial to replace Michaels in S&P 600 at open on 4/15 04/13/21 Apollo to acquire majority stake in ABC Technologies for C$10.00 per share OMF KKR APO BEN VCTR MS GS OMF OneMain Holdings $55.96 / +0.73 (+1.32%) 04/15/21 JPMorgan OneMain Holdings price target lowered to $64 from $65 at JPMorgan 02/11/21 Piper Sandler OneMain secondary creates buying opportunity, says Piper Sandler 02/10/21 Northland OneMain Holdings price target raised to $60 from $45 at Northland 02/10/21 Citi OneMain Holdings price target raised to $62 from $45 at Citi KKR KKR $53.29 / +0.36 (+0.68%) 04/14/21 BMO Capital KKR price target raised to $71 from $69 at BMO Capital 04/14/21 Credit Suisse KKR price target raised to $60 from $53 at Credit Suisse 04/14/21 Deutsche Bank KKR price target raised to $52 from $47 at Deutsche Bank 04/14/21 Citi Citi boosts KKR target to $65, removes from US Focus List APO Apollo Global $51.54 / +1.27 (+2.53%) 04/14/21 Fly Intel: Top five analyst upgrades 04/14/21 Oppenheimer Apollo Global upgraded to Outperform at Oppenheimer 04/14/21 Oppenheimer Apollo Global upgraded to Outperform from Perform at Oppenheimer 04/12/21 Wells Fargo Apollo Global price target lowered to $57 from $62 at Wells Fargo BEN Franklin Resources $30.05 / -0.24 (-0.79%) 04/09/21 Deutsche Bank Franklin Resources price target raised to $29 from $26 at Deutsche Bank 03/29/21 BMO Capital Franklin Resources upgraded to Outperform from Market Perform at BMO Capital 01/28/21 Invesco upgraded to Buy from Neutral at UBS 01/25/21 Barclays Franklin Resources price target raised to $24 from $21 at Barclays VCTR Victory Capital $27.48 / -0.25 (-0.90%) 04/09/21 BofA Victory Capital double-upgraded to Buy from Underperform at BofA 04/09/21 BofA Victory Capital upgraded to Buy from Underperform at BofA 11/19/20 Fly Intel: Top five analyst downgrades 11/19/20 BofA Victory Capital double-downgraded to Underperform from Buy at BofA MS Morgan Stanley $78.58 / -2.31 (-2.86%) 04/16/21 Wells Fargo Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss 04/09/21 JMP Securities Goldman Sachs price target raised to $400 from $338 at JMP Securities 04/07/21 Barclays Morgan Stanley price target raised to $98 from $95 at Barclays 04/01/21 Deutsche Bank Morgan Stanley price target raised to $79 from $68 at Deutsche Bank GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/16/21 BMO Capital Goldman Sachs price target raised to $432 from $409 at BMO Capital 04/15/21 DA Davidson Goldman Sachs price target raised to $378 from $347 at DA Davidson 04/15/21 Oppenheimer Goldman Sachs price target raised to $497 from $468 at Oppenheimer 04/15/21 Credit Suisse Goldman Sachs price target raised to $400 from $395 at Credit Suisse VCTR OMF MS KKR GS BEN APO VCTR Victory Capital $27.48 / -0.25 (-0.90%) 02/10/21 Victory Capital reports Q4 adjusted EPS $1.07, consensus $1.02 11/04/20 Victory Capital reports Q3 adjusted EPS $1.00, consensus 93c OMF OneMain Holdings $55.96 / +0.73 (+1.32%) 02/08/21 OneMain Holdings reports Q4 EPS $2.67, consensus $2.00 10/26/20 OneMain Holdings reports Q3 EPS $1.86, consensus $1.22 MS Morgan Stanley $78.58 / -2.31 (-2.86%) 04/16/21 Morgan Stanley reports Q1 EPS $2.19, consensus $1.70 04/15/21 Notable companies reporting before tomorrow's open 04/14/21 Fly Intel: What to watch in next round of big bank earnings reports KKR KKR $53.29 / +0.36 (+0.68%) 04/14/21 KKR targets $4.00-$5.00 in after-tax distributable earnings per share in 2023-24 02/08/21 KKR reports Q4 EPS 49c, consensus 40c 02/08/21 Notable companies reporting after market close 10/30/20 KKR reports Q3 EPS 48c, consensus 40c GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/14/21 Goldman Sachs reports Q1 EPS $18.60, consensus $10.22 04/13/21 Fly Intel: What to watch in first round of big bank earnings reports 04/13/21 Notable companies reporting before tomorrow's open 01/19/21 Goldman Sachs reports Q4 EPS $12.08, consensus $7.47 BEN Franklin Resources $30.05 / -0.24 (-0.79%) 02/02/21 Franklin Resources reports Q1 adjusted EPS 73c, consensus 72c 10/27/20 Franklin Resources reports Q4 EPS 56c, consensus 67c APO Apollo Global $51.54 / +1.27 (+2.53%) 03/22/21 Apollo CEO Leon Black stepping down to focus on family, health 02/03/21 Apollo Global reports Q4 fee related EPS 63c, consensus 50c 02/02/21 Notable companies reporting before tomorrow's open 11 Feb 11 Nov MS KKR GS APO MS Morgan Stanley $78.58 / -2.31 (-2.86%) 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/06/21 Morgan Stanley sold $5B in Archegos positions on March 25, CNBC says 04/01/21 Morgan Stanley plans to raise dividend when Fed lifts restrictions, CNBC says 03/30/21 Archegos banks, counterparties discuss limiting market fallout, FT reports KKR KKR $53.29 / +0.36 (+0.68%) 04/13/21 KKR, Brookfield Asset Management mulling bid for Toshiba, Bloomberg reports 04/13/21 KKR near deal to buy IT services provider Ensono, Reuters says 04/13/21 KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports 03/23/21 Thoma Bravo to acquire Calabrio from KKR, no terms, Reuters reports GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/16/21 Goldman's corporate communications head to leave bank, NY Times reports 04/10/21 Goldman Sachs had strong pandemic, still room to run, Barron's says 04/08/21 Sen. Brown seeks details of banks' ties to Archegos Capital, CNBC reports APO Apollo Global $51.54 / +1.27 (+2.53%) 04/15/21 Apollo Global considers opening offices in Florida, Europe, Bloomberg says 04/13/21 Black attended Apollo Global meeting days after resignation, FT reports 04/09/21 Apollo Global's Leon Black exit after sexual harassment claims, NY Post reports 04/01/21 Pioneer Natural near deal to acquire DoublePoint Energy for $6B, Reuters says MS KKR GS APO MS Morgan Stanley $78.58 / -2.31 (-2.86%) 04/16/21 Fly Intel: Wall Street's top stories for Friday 04/16/21 Fly Intel: Wall Street's top stories at midday 04/16/21 Fly Intel: Pre-market Movers 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues KKR KKR $53.29 / +0.36 (+0.68%) 04/13/21 Game On: GameStop may be looking for new CEO 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Game On: Microsoft completes Bethesda deal, promises exclusive games GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/14/21 Fly Intel: Wall Street's top stories for Wednesday 04/14/21 Fly Intel: Wall Street's top stories at midday 04/14/21 Fly Intel: Pre-market Movers 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street APO Apollo Global $51.54 / +1.27 (+2.53%) 03/25/21 Fly Intel: Wall Street's Top Stories for Thursday 03/22/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories for Monday 03/08/21 Fly Intel: Wall Street's top stories at midday 04/27/21 OneMain Holdings - OMF 05/04/21 Apollo Global - APO 05/07/21 Victory Capital - VCTR 04/20/21 Goldman Sachs 04/29/21 Goldman Sachs Group Inc. 05/13/21 Victory Capital 05/18/21 Victory Capital Holdings, Inc. 05/20/21 Morgan Stanley Co. 05/25/21 OneMain Holdings, Inc. VCTR MS GS BEN APO VCTR Victory Capital $27.48 / -0.25 (-0.90%) 01/06/21 Fifteen new option listings on January 6th MS Morgan Stanley $78.58 / -2.31 (-2.86%) 03/29/21 Unusually active option classes on open March 29th 03/18/21 Morgan Stanley call volume above normal and directionally bullish 02/16/21 Morgan Stanley call volume above normal and directionally bullish 01/29/21 Morgan Stanley put volume heavy and directionally bearish GS Goldman Sachs $342.30 / +3.71 (+1.10%) 04/16/21 Unusually active option classes on open April 16th 04/09/21 Unusually active option classes on open April 9th 03/30/21 Unusually active option classes on open March 30th BEN Franklin Resources $30.05 / -0.24 (-0.79%) 03/29/21 Early notable gainers among liquid option names on March 29th 03/10/21 Early notable gainers among liquid option names on March 10th APO Apollo Global $51.54 / +1.27 (+2.53%) 03/17/21 $2.2M put block in Apollo Global Management suggests confidence into summer 10/22/20 Apollo Global put volume heavy and directionally bearish

Saturday
On The Fly	Opening Day: Coinbase soars in market debut » 09:03 04/17/21 04/17 09:03 04/17/21 09:03 RXRX Recursion Pharmaceuticals $31.06 / +0.81 (+2.68%) , BMEA Biomea Fusion $18.48 / -1.92 (-9.41%) , AKYA Akoya Biosciences $26.92 / +0.18 (+0.67%) , APP AppLovin $61.01 / -3.795 (-5.86%) , AGL Agilon Health $30.45 / -0.43 (-1.39%) , KRT Karat Packaging $18.38 / -0.52 (-2.75%) , TSP TuSimple $39.99 / +0.53 (+1.34%) , EBET Esports Technologies $25.35 / -10.69 (-29.66%) , COIN Coinbase $341.27 / +15.78 (+4.85%) , ALKT Alkami $42.13 / -0.13 (-0.31%) , SQSP Squarespace / + , SVFD Save Foods / + , RGCB Regencell Bioscience / + , SWIM Latham Group / + , EDR Endeavor $41.49 / + (+0.00%) , UBER Uber $60.34 / -0.405 (-0.67%) , LYFT Lyft $63.36 / -1.07 (-1.66%) Shares of Coinbase jumped… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options UBER LYFT COIN UBER Uber $60.34 / -0.405 (-0.67%) 04/12/21 Uber CEO tells CNBC it may get into cannabis delivery 04/12/21 Uber says on track to reach quarterly adjusted EBITDA profitability in 2021 04/12/21 Uber says March 2021 Gross Bookings at highest monthly level in company history 04/07/21 Uber launching $250M driver stimulus program LYFT Lyft $63.36 / -1.07 (-1.66%) 04/12/21 Lyft CFO sells 15K shares of common stock 03/30/21 Lyft director sells 222K shares of common stock 03/24/21 Delta partners with Lyft to support COVID vaccine access by funding rides 03/18/21 Lyft reports first positive y/y growth in daily rideshare ride volume in a year COIN Coinbase $341.27 / +15.78 (+4.85%) 04/14/21 Cathie Wood's ARK Investment discloses 752.2K shares of Coinbase bought today 04/13/21 Coinbase updates on conversion of Class B shares to Class A shares 04/06/21 Crypto Council for Innovation launches with Square,Coinbase, Fidelity as members 03/22/21 Coinbase ordered to pay $6.5M by CFTC for false, misleading reporting RXRX BMEA AKYA APP AGL KRT TSP EBET COIN ALKT SQSP SVFD RGCB SWIM EDR UBER LYFT RXRX Recursion Pharmaceuticals $31.06 / +0.81 (+2.68%) BMEA Biomea Fusion $18.48 / -1.92 (-9.41%) AKYA Akoya Biosciences $26.92 / +0.18 (+0.67%) APP AppLovin $61.01 / -3.795 (-5.86%) AGL Agilon Health $30.45 / -0.43 (-1.39%) KRT Karat Packaging $18.38 / -0.52 (-2.75%) TSP TuSimple $39.99 / +0.53 (+1.34%) EBET Esports Technologies $25.35 / -10.69 (-29.66%) COIN Coinbase $341.27 / +15.78 (+4.85%) 04/15/21 Loop Capital Loop Capital starts Coinbase at Buy, sees 'lots of runway before takeoff' 04/15/21 Loop Capital Coinbase initiated with a Buy at Loop Capital 04/15/21 Fly Intel: Top five analyst initiations 04/15/21 DA Davidson Coinbase price target raised to $650 from $440 at DA Davidson ALKT Alkami $42.13 / -0.13 (-0.31%) SQSP Squarespace / + SVFD Save Foods / + RGCB Regencell Bioscience / + SWIM Latham Group / + EDR Endeavor $41.49 / + (+0.00%) UBER Uber $60.34 / -0.405 (-0.67%) 04/12/21 Truist Uber's March update 'bodes well' for Q1 and FY21 outlook, says Truist 04/05/21 Evercore ISI Uber assumed with an Outperform at Evercore ISI 04/01/21 Fly Intel: Top five analyst initiations 04/01/21 Jefferies Uber initiated with a Buy at Jefferies LYFT Lyft $63.36 / -1.07 (-1.66%) 04/05/21 Evercore ISI Lyft assumed with an Outperform at Evercore ISI 03/31/21 Wolfe Research Lyft assumed with a Peer Perform at Wolfe Research 03/26/21 Fly Intel: Top five analyst initiations 03/26/21 Vertical Research Lyft initiated with a Buy at Vertical Research UBER LYFT COIN UBER Uber $60.34 / -0.405 (-0.67%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/10/21 Uber reports Q4 EPS (54c), consensus (55c) 02/10/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports LYFT Lyft $63.36 / -1.07 (-1.66%) 02/09/21 Lyft reports Q4 revenue $569.9M, consensus $562.49M 02/09/21 Notable companies reporting after market close 12/02/20 Lyft sees Q4 sequential revenue growth at lower end of 11%-15% range 11/10/20 Lyft reports Q3 adj. EPS (89c), consensus (91c) COIN Coinbase $341.27 / +15.78 (+4.85%) 04/06/21 Coinbase gives Q2, FY21 expenses guidance 04/06/21 Coinbase reports Q1 estimated total revenue of $1.8B 23 Apr 14 Apr 15 Apr 16 Apr 16 Apr 16 Apr 15 Apr 15 Apr 15 Apr 14 Apr 15 Apr 08 Jan UBER TSP LYFT COIN UBER Uber $60.34 / -0.405 (-0.67%) 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 04/09/21 China's Didi Chuxing files confidentially for U.S. IPO, Bloomberg says 03/31/21 British IPO of Amazon-backed Deliveroo stumbles, Bloomberg reports 03/30/21 Accusations of 'poor pay' blemish Britain's Deliveroo IPO, NY Times reports TSP TuSimple $39.99 / +0.53 (+1.34%) 04/14/21 TuSimple IPO to price at $40, above $35-$39 target range, Bloomberg says LYFT Lyft $63.36 / -1.07 (-1.66%) 03/26/21 Judge rules lawsuit over Uber, Lyft driver status can proceed, Reuters reports 01/12/21 Uber, Lyft drivers and union sue over Prop. 22, Axios reports COIN Coinbase $341.27 / +15.78 (+4.85%) 04/06/21 Coinbase's independent directors will have direct ties to company, WSJ reports 03/21/21 Coinbase direct listing pushed back to April, Bloomberg reports 02/19/21 'Heard on the Street' highlights PayPal, Square among crypto-exposure names 12/17/20 Coinbase filed confidentially for IPO, Bloomberg says UBER SQSP LYFT EBET COIN AGL UBER Uber $60.34 / -0.405 (-0.67%) 04/12/21 Fly Intel: Wall Street's top stories for Monday 04/12/21 Fly Intel: Wall Street's top stories at midday 04/12/21 Fly Intel: Pre-market Movers SQSP Squarespace / + 04/16/21 Fly Intel: Wall Street's top stories for Friday LYFT Lyft $63.36 / -1.07 (-1.66%) 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street 04/01/21 Alphabet, Facebook initiations among today's top calls on Wall Street 03/03/21 Fly Intel: Wall Street's top stories for Wednesday EBET Esports Technologies $25.35 / -10.69 (-29.66%) 04/16/21 Fly Intel: Pre-market Movers COIN Coinbase $341.27 / +15.78 (+4.85%) 04/16/21 Cisco, Comcast upgrades among today's top calls on Wall Street 04/16/21 The Intersection: Crypto and Wall Street This Week 04/15/21 Intel downgrade, UPS upgrade among today's top calls on Wall Street 04/14/21 Fly Intel: Wall Street's top stories for Wednesday AGL Agilon Health $30.45 / -0.43 (-1.39%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/03/21 Opening Day: Softbank-backed Compass raises $450M in IPO 03/27/21 Opening Day: Vizio slides in NYSE debut after downsized IPO 03/20/21 Opening Day: China's Tuya raised $915M in U.S. IPO 05/24/21 Global Technology, Media & Communications Virtual Conference 05/04/21 Lyft - LYFT 05/05/21 Uber - UBER 05/10/21 Uber Technologies, Inc. UBER LYFT UBER Uber $60.34 / -0.405 (-0.67%) 02/25/21 Uber call volume above normal and directionally bullish 02/10/21 Uber options imply 11.7% move in share price post-earnings 01/11/21 Uber call volume above normal and directionally bullish 01/07/21 Uber call volume above normal and directionally bullish LYFT Lyft $63.36 / -1.07 (-1.66%) 03/15/21 Lyft call buyer realizes 5% same-day gains 03/12/21 Lyft call volume above normal and directionally bullish 03/05/21 Lyft call volume above normal and directionally bullish 02/25/21 Lyft call volume above normal and directionally bullish

Friday
On The Fly	Bet On It: Arizona legalizes sports betting, while Maryland nears finish line » 16:03 04/16/21 04/16 16:03 04/16/21 16:03 DKNG DraftKings $57.96 / +0.465 (+0.81%) , CZR Caesars $93.59 / +0.4 (+0.43%) , PDYPY Flutter Entertainment $109.10 / +3.03 (+2.86%) , BALY Bally's $58.60 / +1.1 (+1.91%) , JKPTF Gamesys Group $26.80 / +0.3 (+1.13%) , LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) , ACEL Accel Entertainment $11.87 / +0.18 (+1.54%) , BYD Boyd Gaming $65.85 / +0.73 (+1.12%) , CHDN Churchill Downs $220.43 / +3.02 (+1.39%) , GAN Gan Limited $18.29 / +0.3 (+1.67%) , MGM MGM Resorts $40.25 / +0.57 (+1.44%) , PENN Penn National $99.86 / -0.81 (-0.80%) , SGMS Scientific Games $47.37 / +2.46 (+5.48%) , SCR Score Media $21.05 / +2.3 (+12.27%) , WIMHY William Hill $15.12 / +0.14 (+0.93%) , WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) , RSI Rush Street Interactive $14.39 / +0.06 (+0.42%) Welcome to the latest… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options WYNN SGMS RSI PENN PDYPY MGM LVS JKPTF GAN DKNG CZR CHDN BYD BALY ACEL WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 04/08/21 WynnBET partners with digital sports media publisher Minute Media 04/01/21 WynnBET announces launch of mobile sports book in Indiana SGMS Scientific Games $47.37 / +2.46 (+5.48%) 04/15/21 Scientific Games announces Victor Blanco to join company as CTO in 2022 03/30/21 Exacta Systems signs agreement with Scientific Games 03/01/21 Scientific Games drops 5% to $48.00 after reporting Q4 results 03/01/21 International Game, Scientific Games sign cross-licensing agreement RSI Rush Street Interactive $14.39 / +0.06 (+0.42%) 04/12/21 Rush Street announces launch in West Virginia of BetRivers.com 03/24/21 Spin Games' i-gaming products go live in Michigan with Rush Street Interactive 03/11/21 Rush Street Interactive rises 13.8% 02/22/21 Rush Street Interactive enters strategic partnership with Penn National PENN Penn National $99.86 / -0.81 (-0.80%) 04/13/21 Gaming and Leisure Properties to acquire some of Bally's assets for $150M 04/06/21 Dave Portnoy tweets regarding decline in Penn National shares 03/26/21 PointsBet extends online gaming services framework agreement with Penn National PDYPY Flutter Entertainment $109.10 / +3.03 (+2.86%) 04/06/21 Fox Corp. says sued Flutter to 'enforce its rights' to acquire FanDuel stake 03/25/21 Flutter says Kentucky Supreme Court denies petition for rehearing MGM MGM Resorts $40.25 / +0.57 (+1.44%) 04/07/21 MGM Resorts adds enhancements to Convene with Confidence program 03/31/21 Detroit Tigers enters sponsorship agreement with BetMGM LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 04/01/21 Macau reports March casino revenue up 58.0% to 8.31B patacas 03/03/21 VICI Properties to acquire Venetian Resort's real estate in Las Vegas for $4B JKPTF Gamesys Group $26.80 / +0.3 (+1.13%) 04/13/21 Bally's to combine with Gamesys Group 03/24/21 Bally's reports agreement in principle to buy Gamesys Group plc GAN Gan Limited $18.29 / +0.3 (+1.67%) 03/17/21 Gan Limited enters simulated gaming solutions agreement with Gila 02/25/21 Bill introduced in Florida Senate to authorize sports wagering DKNG DraftKings $57.96 / +0.465 (+0.81%) 04/15/21 DraftKings to become NFL betting partner, extend current fantasy relationship 04/14/21 DraftKing, PGA TOUR expand relationship with Arizona market access 04/13/21 DraftKings names Brian Angiolet as first-ever chief media officer 04/07/21 New York state budget for fiscal 2022 legalizes mobile sports betting CZR Caesars $93.59 / +0.4 (+0.43%) 04/15/21 Caesars expands partnership with National Football League 03/25/21 Nevada reports statewide February gaming win down 26% to $772.41M 03/22/21 Penn National, Generac, Caesars set to move to S&P 500 at open on 3/22 03/18/21 Connecticut Governor Lamont, tribes reach gambling agreement CHDN Churchill Downs $220.43 / +3.02 (+1.39%) 03/18/21 Churchill Downs launches TwinSpires Sports mobile app in Tennessee 03/16/21 Churchill Downs announces four-year partnership with Kendall-Jackson, La Crema BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 03/08/21 Boyd Gaming, FanDuel to launch Stardust-branded online casinos in NJ, PA 03/02/21 Boyd Gaming and Wilton Rancheria Tribe to begin construction of gaming resort BALY Bally's $58.60 / +1.1 (+1.91%) 04/16/21 Bally's to provide plan for Richmond residents to own equity in Richmond Casino 04/15/21 Ballys trading resumes 04/15/21 Bally's to pursue strategic investment in lieu of tangible equity unit offering 04/15/21 Ballys trading halted, news pending ACEL Accel Entertainment $11.87 / +0.18 (+1.54%) 03/02/21 Accel Entertainment expands into Montana and Nevada, acquiring Century Gaming DKNG CZR PDYPY BALY JKPTF LVS ACEL BYD CHDN GAN MGM PENN SGMS SCR WIMHY WYNN RSI DKNG DraftKings $57.96 / +0.465 (+0.81%) 04/07/21 Truist Truist sees NY budget agreement's mobile sports betting deal as 'clear as mud' 04/06/21 Credit Suisse Reports, contacts point to sports betting momentum in NY, Credit Suisse says 04/01/21 Credit Suisse NY online sports betting likely to make it into budget, says Credit Suisse 03/30/21 Loop Capital Loop Capital recommends buying DraftKings going into NY budget deadline CZR Caesars $93.59 / +0.4 (+0.43%) 04/08/21 KeyBanc Caesars price target raised to $110 from $102 at KeyBanc 04/05/21 Fly Intel: Top five analyst upgrades PDYPY Flutter Entertainment $109.10 / +3.03 (+2.86%) 04/12/21 RBC Capital Flutter price target raised to 17,000 GBp from 15,700 GBp at RBC Capital 03/30/21 Barclays Flutter price target raised to 17,500 GBp from 15,000 GBp at Barclays BALY Bally's $58.60 / +1.1 (+1.91%) 04/08/21 KeyBanc Bally's price target raised to $70 from $65 at KeyBanc 03/29/21 Truist Early March casino data looks 'very positive,' says Truist 03/25/21 Stifel Bally's price target raised to $75 from $70 at Stifel 03/24/21 Jefferies Gamesys Group and Bally's an 'interesting combination,' says Jefferies JKPTF Gamesys Group $26.80 / +0.3 (+1.13%) 04/14/21 Canaccord Gamesys Group downgraded to Hold on merger at Canaccord 04/14/21 Canaccord Gamesys Group downgraded to Hold from Buy at Canaccord 03/16/21 Jefferies Gamesys Group price target raised to 2,150 GBp from 1,930 GBp at Jefferies LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 03/29/21 Deutsche Bank New York may be 'kicking the can' on sports betting, says Deutsche 03/18/21 JPMorgan Micro-betting market in U.S. 'could be substantial,' says JPMorgan ACEL Accel Entertainment $11.87 / +0.18 (+1.54%) 04/08/21 JPMorgan Accel Entertainment initiated with an Overweight at JPMorgan 03/16/21 Deutsche Bank Accel Entertainment price target raised to $13 from $12 at Deutsche Bank 03/08/21 Macquarie Accel Entertainment initiated with a Neutral at Macquarie 03/08/21 Macquarie Accel Entertainment initiated with a Neutral at Macquarie BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 04/16/21 Deutsche Bank Boyd Gaming price target raised to $71 from $67 at Deutsche Bank 04/08/21 KeyBanc Boyd Gaming price target raised to $69 from $61 at KeyBanc 04/05/21 Morgan Stanley Caesars upgraded to Overweight from Equal Weight at Morgan Stanley CHDN Churchill Downs $220.43 / +3.02 (+1.39%) 03/01/21 KeyBanc Churchill Downs price target raised to $250 from $239 at KeyBanc 02/09/21 Morgan Stanley Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds GAN Gan Limited $18.29 / +0.3 (+1.67%) 03/26/21 Fly Intel: Top five analyst downgrades 03/26/21 Craig-Hallum Gan Limited downgraded to Hold from Buy at Craig-Hallum MGM MGM Resorts $40.25 / +0.57 (+1.44%) 04/05/21 Morgan Stanley Morgan Stanley upgrades MGM Resorts to Overweight after Vegas visit PENN Penn National $99.86 / -0.81 (-0.80%) SGMS Scientific Games $47.37 / +2.46 (+5.48%) 03/04/21 Credit Suisse Scientific Games price target raised to $35 from $9 at Credit Suisse 02/09/21 Craig-Hallum Scientific Games Digital segment still 'underappreciated,' says Craig-Hallum 01/19/21 Jefferies Scientific Games price target raised to $55 from $50 at Jefferies 01/14/21 Truist Scientific Games price target raised to $60 from $45 at Truist SCR Score Media $21.05 / +2.3 (+12.27%) 03/23/21 Credit Suisse Score Media initiated with an Outperform at Credit Suisse 03/22/21 Macquarie Score Media initiated with an Outperform at Macquarie WIMHY William Hill $15.12 / +0.14 (+0.93%) WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 04/06/21 Fly Intel: Top five analyst upgrades 04/06/21 Argus Wynn Resorts upgraded to Buy from Hold at Argus RSI Rush Street Interactive $14.39 / +0.06 (+0.42%) 04/16/21 Fly Intel: Top five analyst initiations 04/16/21 Jefferies Jefferies starts Rush Street Interactive at Buy with $21 price target 04/16/21 Jefferies Rush Street Interactive initiated with a Buy at Jefferies WYNN SGMS RSI PENN MGM LVS GAN DKNG CZR CHDN BYD BALY ACEL WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 02/04/21 Wynn Resorts reports Q4 adjusted EPS ($2.45), consensus ($2.31) 02/04/21 Notable companies reporting after market close 11/05/20 Wynn Resorts reports Q3 adjusted EPS ($7.04), consensus ($4.02) SGMS Scientific Games $47.37 / +2.46 (+5.48%) 03/30/21 Scientific Games launches lottery instant game sales in groceries 03/01/21 Scientific Games reports Q4 EPS (95c), consensus (47c) 11/04/20 Scientific Games reports Q3 EPS ($1.23), consensus (77c) 11/04/20 Scientific Games reports Q3 EPS ($1.23), consensus (77c) RSI Rush Street Interactive $14.39 / +0.06 (+0.42%) 03/10/21 Rush Street raises FY21 revenue view to $420M-$460M from $320M 03/10/21 Rush Street Interactive reports Q4 EPS (1c), consensus (32c) PENN Penn National $99.86 / -0.81 (-0.80%) 02/04/21 Penn National reports Q4 EPS 7c, consensus 24c 02/03/21 Notable companies reporting before tomorrow's open 10/29/20 Penn National reports Q3 EPS 93c, consensus 53c MGM MGM Resorts $40.25 / +0.57 (+1.44%) 02/10/21 MGM Resorts reports Q4 adjusted EPS (90c), consensus (90c) 02/10/21 Notable companies reporting after market close 10/29/20 MGM Resorts reports Q3 adjusted EPS ($1.08), consensus ($1.04) 10/29/20 Notable companies reporting after market close LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 01/27/21 Las Vegas Sands reports Q4 adjusted EPS (37c), consensus (32c) 01/27/21 Notable companies reporting after market close 10/21/20 Las Vegas Sands reports Q3 adjusted EPS (67c), consensus (59c) 10/21/20 Notable companies reporting after market close GAN Gan Limited $18.29 / +0.3 (+1.67%) 03/25/21 Gan Limited sees Q1 revenue $24M-$25M, consensus $17.18M 03/25/21 Gan Limited sees FY21 revenue $100M-$105M, consensus $98.57M 03/25/21 Gan Limited reports Q4 EPS (27c), consensus (6c) 11/16/20 Gan Limited backs FY20 revenue view $37M-$39M, consensus $38.11M DKNG DraftKings $57.96 / +0.465 (+0.81%) 02/26/21 DraftKings raises 2021 revenue view to $900M-$1B from $750M-$850M 02/26/21 DraftKings reports Q4 revenue $322M, consensus $232.6M 02/25/21 Notable companies reporting before tomorrow's open CZR Caesars $93.59 / +0.4 (+0.43%) 02/25/21 Caesars reports Q4 EPS ($1.91), consensus ($1.76) 02/25/21 Notable companies reporting after market close 11/05/20 Caesars reports Q3 EPS ($6.09), consensus ($2.15) 11/05/20 Notable companies reporting after market close CHDN Churchill Downs $220.43 / +3.02 (+1.39%) 02/24/21 Churchill Downs reports Q4 adjusted EPS 19c, consensus 27c 10/28/20 Churchill Downs reports Q3 adj. EPS $1.19, two estimates 74c BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 02/16/21 Boyd Gaming reports Q4 adjusted EPS 46c, consensus 39c 02/16/21 Notable companies reporting after market close 10/26/20 Boyd Gaming reports Q3 adjusted EPS 38c, consensus 10c 10/26/20 Notable companies reporting after market close BALY Bally's $58.60 / +1.1 (+1.91%) 04/13/21 Bally's sees Q1 revenue $185M, consensus $156.45M 03/04/21 Bally's reports Q4 adjusted EPS 39c, consensus (8c) 11/09/20 Bally's Corporation changes name from Twin River Worldwide Holdings ACEL Accel Entertainment $11.87 / +0.18 (+1.54%) 03/15/21 Accel Entertainment sees FY21 revenue $580M-$600M, consensus $545.67M 03/15/21 Accel Entertainment reports Q4 revenue $74.41M, consensus $80.83M 11/05/20 Accel Entertainment reports Q3 adjusted net income $15.42M vs. $6.323M in Q319 16 Apr 25 Feb 09 Feb 17 Dec 07 Oct 29 Sep 25 Sep 24 Sep 19 Jun 12 May 05 May WYNN SCR PDYPY LVS DKNG CZR BYD BALY WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 04/09/21 Wynn Resorts won't mandate Covid vaccinations, CEO tells Cramer on 'Mad Money' SCR Score Media $21.05 / +2.3 (+12.27%) 03/01/21 DraftKings exploring acquisitions, TheScore on its radar, Business Insider says PDYPY Flutter Entertainment $109.10 / +3.03 (+2.86%) 04/06/21 Fox files suit against Flutter over disputed FanDuel option, CNBC reports 03/20/21 Investors may want to keep betting on Flutter stock, Barron's says LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 04/14/21 Las Vegas Sands running ads to campaign for Texas casinos, Texas Tribune reports DKNG DraftKings $57.96 / +0.465 (+0.81%) 04/13/21 DraftKings in final stages of hiring chief media officer, Axios reports 04/06/21 New York to approve online sports betting model backed by Cuomo, Action says 03/13/21 Flutter considering listing some of its FanDuel business, Reuters reports 03/02/21 Hedgeye adds DraftKings as a Best Idea Short CZR Caesars $93.59 / +0.4 (+0.43%) 03/23/21 Caesars sues insurance carriers for refusing to cover $2B+ of losses, WSJ says 02/12/21 Nevada to roll back capacity restrictions on casinos, Reno Gazette Journal says 02/09/21 TX Lt. Gov. sees no support for legalized sports betting, Houston Chronicle says 01/21/21 Japan expects Tokyo Olympics will have to be cancelled, The Times says BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 01/11/21 NBA postones Pelicans-Mavs, Celtics-Bulls games BALY Bally's $58.60 / +1.1 (+1.91%) 03/10/21 Casino companies prepare to compete for NYC-area license, NY Post reports WYNN LVS JKPTF GAN DKNG CZR BYD BALY WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 04/06/21 Roku, Starbucks initiations among today's top calls on Wall Street LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 04/01/21 Macau gaming revenue continues streak, gaining 58% year-over-year in March JKPTF Gamesys Group $26.80 / +0.3 (+1.13%) 03/24/21 Fly Intel: Wall Street's top stories for Wednesday 03/24/21 Fly Intel: Wall Street's top stories at midday GAN Gan Limited $18.29 / +0.3 (+1.67%) 03/26/21 Fly Intel: Wall Street's top stories at midday DKNG DraftKings $57.96 / +0.465 (+0.81%) 04/15/21 Fly Intel: After-Hours Movers 04/09/21 Bet On It: Mobile sports betting added to budget in New York 04/01/21 Bet On It: Sports betting operators make more content-related deals 03/30/21 Fly Intel: Wall Street's top stories for Tuesday CZR Caesars $93.59 / +0.4 (+0.43%) 03/26/21 Bet On It: Las Vegas recovery potentially underway as restrictions loosen 03/19/21 Bet On It: Connecticut governor, two tribes in agreement on sports betting BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 03/12/21 Bet On It: DraftKings boasts scale and market share at investor day BALY Bally's $58.60 / +1.1 (+1.91%) 04/13/21 Fly Intel: Wall Street's top stories for Tuesday 04/13/21 Fly Intel: Wall Street's top stories at midday 04/13/21 Fly Intel: Pre-market Movers 04/21/21 Las Vegas Sands - LVS 04/22/21 Churchill Downs - CHDN 04/27/21 Boyd Gaming - BYD 04/28/21 MGM Resorts - MGM 05/04/21 Caesars - CZR 05/06/21 Penn National - PENN 05/07/21 DraftKings - DKNG 04/20/21 Churchill Downs Incorporated 04/21/21 MGM Resorts 04/21/21 MGM Resorts International 04/28/21 DraftKings Inc 05/05/21 Wynn Resorts Ltd. 05/05/21 MGM Resorts International 05/05/21 Accel Entertainment Inc 05/06/21 Boyd Gaming Corp 05/13/21 Las Vegas Sands Corp. 05/18/21 Bally's Corporation 06/10/21 Rush Street Interactive Inc WYNN SGMS SCR RSI PENN MGM LVS GAN DKNG CZR BYD WYNN Wynn Resorts $127.47 / -0.43 (-0.34%) 03/03/21 Wynn Resorts call volume above normal and directionally bullish 02/10/21 Wynn Resorts call volume above normal and directionally bullish 11/24/20 Wynn Resorts call volume above normal and directionally bullish SGMS Scientific Games $47.37 / +2.46 (+5.48%) 04/16/21 Scientific Games call buyer realizes 17% same-day gains SCR Score Media $21.05 / +2.3 (+12.27%) 03/24/21 new option listings on March 24th RSI Rush Street Interactive $14.39 / +0.06 (+0.42%) 02/25/21 Largest borrow rate increases among liquid names 01/26/21 Largest borrow rate increases among liquid names 01/05/21 Largest borrow rate increases among liquid names 12/30/20 Three new option listings and four option delistings on December 30th PENN Penn National $99.86 / -0.81 (-0.80%) 03/01/21 Unusually active option classes on open March 1st 01/12/21 Penn National call volume above normal and directionally bullish 12/16/20 Penn National call volume above normal and directionally bullish 12/14/20 Penn National call volume above normal and directionally bullish MGM MGM Resorts $40.25 / +0.57 (+1.44%) 04/07/21 Call buyer rolls the dice in MGM Resorts 04/05/21 Unusually active option classes on open April 5th 03/15/21 MGM Resorts call volume above normal and directionally bullish LVS Las Vegas Sands $61.09 / -0.21 (-0.34%) 02/11/21 Las Vegas Sands put volume heavy and directionally bearish 02/05/21 Early notable gainers among liquid option names on February 5th 01/27/21 Las Vegas Sands call volume above normal and directionally bullish 11/02/20 Unusually active option classes on open November 2nd GAN Gan Limited $18.29 / +0.3 (+1.67%) 03/25/21 GAN Ltd options imply 14.9% move in share price post-earnings 01/22/21 GAN Ltd put volume heavy and directionally bearish 10/28/20 Largest borrow rate increases among liquid names 10/22/20 Largest borrow rate increases among liquid names DKNG DraftKings $57.96 / +0.465 (+0.81%) 04/16/21 Unusually active option classes on open April 16th 04/12/21 Unusual call flow in option market yesterday 03/22/21 DraftKings call sale likely closing 03/08/21 DraftKings call volume above normal and directionally bullish CZR Caesars $93.59 / +0.4 (+0.43%) 04/07/21 Unusually active option classes on open April 7th 04/06/21 Early notable gainers among liquid option names on April 6th 04/05/21 Early notable gainers among liquid option names on April 5th 11/24/20 Caesars call volume above normal and directionally bullish BYD Boyd Gaming $65.85 / +0.73 (+1.12%) 10/26/20 Boyd Gaming options imply 9.7% move in share price post-earnings
Options	Nordstrom put volume heavy and directionally bearish » 11:35 04/16/21 04/16 11:35 04/16/21 11:35 JWN Nordstrom $35.33 / -0.58 (-1.62%) Bearish flow noted in… Bearish flow noted in Nordstrom with 1,260 puts trading, or 1.3x expected. Most active are May-21 32.5 puts and Apr-21 30 puts, with total volume in those strikes near 460 contracts. The Put/Call Ratio is 2.36, while ATM IV is up over 5 points on the day. Earnings are expected on May 27th. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options JWN Nordstrom $35.33 / -0.58 (-1.62%) 03/02/21 Nordstrom says overall trends improved sequentially throughout the quarter 03/02/21 Nordstrom says taking actions to 'significantly reduce inventory levels' in Q1 03/02/21 Nordstrom says Q4 digital sales of about $2B represented 54% of business 03/01/21 Nordstrom, Tonal form partnership JWN Nordstrom $35.33 / -0.58 (-1.62%) 03/12/21 Fly Intel: Top five analyst initiations 03/12/21 Jefferies Jefferies picks Macy's, Kohl's and Nordstrom as department store 'survivors' 03/12/21 Jefferies Nordstrom initiated with a Buy at Jefferies 02/16/21 JPMorgan Nordstrom price target raised to $40 from $34 at JPMorgan JWN Nordstrom $35.33 / -0.58 (-1.62%) 03/02/21 Nordstrom sees FY21 revenue up more than 25%, consensus $13.46B 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 03/02/21 Nordstrom reports Q4 EPS 21c, consensus 14c 02/04/21 Nordstrom gives long-term outlook, sees sales growing low single-digits annually JWN Nordstrom $35.33 / -0.58 (-1.62%) 01/02/21 Nordstrom looks like a department store survivor, Barron's says JWN Nordstrom $35.33 / -0.58 (-1.62%) 03/12/21 Lennar downgrade, Barclays upgrade among today's top calls on Wall Street 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/02/21 Fly Intel: After-Hours Movers 05/19/21 Nordstrom Inc. JWN Nordstrom $35.33 / -0.58 (-1.62%) 04/15/21 Nordstrom put volume heavy and directionally bearish 03/24/21 Nordstrom put volume heavy and directionally bearish 03/02/21 Nordstrom options imply 13.1% move in share price post-earnings 01/29/21 Nordstrom put buyer realizes 156% same-day gains
Hot Stocks	General Motors, LG Energy Solution investing $2.3B in U.S. manufacturing plant » 10:02 04/16/21 04/16 10:02 04/16/21 10:02 GM General Motors $58.71 / +0.1 (+0.17%) Ultium Cells LLC, a joint… Ultium Cells LLC, a joint venture of LG Energy Solution and General Motors, announced a more than $2.3B investment to build its second battery cell manufacturing plant in the United States. The facility will be located in Spring Hill, Tennessee. Ultium Cells will build the new plant on land leased from GM. The new battery cell plant will create 1,300 new jobs. Construction on the approximately 2.8 million-square-foot facility will begin immediately, and the plant is scheduled to open in late 2023. Once operational, the facility will supply battery cells to GM's Spring Hill assembly plant. The Spring Hill plant will use the most advanced and efficient battery cell manufacturing processes. The plant will be extremely flexible and able to adapt to ongoing advances in technology and materials. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GM General Motors $58.71 / +0.1 (+0.17%) 04/16/21 EU passenger car registrations up 87.3% in March, up 3.2% in Q1 04/15/21 Walmart invests in GM-backed self-driving company Cruise 04/12/21 General Motors launches Maps+ in-vehicle navigation solution 04/06/21 GM says Chevrolet will introduce Silverado electric pickup truck GM General Motors $58.71 / +0.1 (+0.17%) 04/14/21 Evercore ISI General Motors price target raised to $65 from $62 at Evercore ISI 04/05/21 Fly Intel: Top five analyst initiations 04/05/21 Wells Fargo General Motors initiated with an Overweight at Wells Fargo 03/29/21 Jefferies General Motors price target raised to $62 from $50 at Jefferies GM General Motors $58.71 / +0.1 (+0.17%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $58.71 / +0.1 (+0.17%) 04/14/21 GM to announce second U.S. battery plant with LG Chem, Reuters reports 04/13/21 GM shortens expected downtime at Tennessee plant, CNBC reports 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/12/21 General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports GM General Motors $58.71 / +0.1 (+0.17%) 04/12/21 Charged: White House proposal calling for $100B in new EV consumer rebates 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries 04/16/21 General Motors - GM 05/05/21 General Motors - GM GM General Motors $58.71 / +0.1 (+0.17%) 04/07/21 Notable open interest changes for April 7th 03/24/21 General Motors call volume above normal and directionally bullish 03/03/21 Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial